Transvenous Optoacoustic-Ultrasound Guided Cold Laser Wire for Crossing Coronary Chronic Total Occlusion
经静脉光声超声引导冷激光线穿越冠状动脉慢性完全闭塞
基本信息
- 批准号:10435198
- 负责人:
- 金额:$ 63.44万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcuteAddressAdipose tissueAffectAmericanAngiographyAnimal ModelAnterior Descending Coronary ArteryArterial Fatty StreakArteriesAtherosclerosisBlood flowBypassCaliberCaliforniaCardiacCardiac TamponadeCardiologyCardiovascular DiseasesCathetersCessation of lifeChest PainChronicClinicComplexComplicationCoronaryCoronary Artery BypassCoronary arteryDevelopmentDevicesDisciplineDiseaseDissectionEndothelial CellsEnvironmentEventFailureFamily suidaeFatigueFiberFrail ElderlyGoalsHealthHeartHeart TransplantationHourHumanImageInjuryInstitutesInterventionLasersLeftLeft Ventricular Ejection FractionLength of StayLesionLightMechanicsMedicalMorbidity - disease rateMyocardial InfarctionOperative Surgical ProceduresOpticsOrgan TransplantationOutcomeParticipantPatient-Focused OutcomesPatientsPerforationPeripheralProceduresProgram DevelopmentRecoveryResearchShortness of BreathSideStentsStructure of left gastric veinSymptomsSystemTechniquesTestingTherapeuticTimeTreatment ProtocolsUltrasonographyUniversitiesVeinsbasecalcificationcell injurycostdesignimage guidedimaging systemimprovedin vivoinnovationminimally invasivemortalitynoveloptical fiberpercutaneous coronary interventionphotoacoustic imagingpressurerandomized controlled studyreal-time imagesreduce symptomsresearch and developmentrestenosissafe patientsoundstent thrombosisultrasound
项目摘要
ABSTRACT
Coronary chronic total occlusions (CTOs) are atherosclerotic plaques comprised of hard fibro-calcific material
that restrict luminal cross-section by 100% resulting in complete stoppage of blood flow in the affected artery for
at least three months. CTO symptoms include shortness of breath with chronic fatigue and chest pain. The
three primary CTO treatment regimens are medical therapy (MT), coronary artery bypass graft (CABG) and
percutaneous coronary interventions (PCI). MT can reduce symptoms such as chest pain but fail to address the
underlying disease mechanisms. CABG does provide marked improvements in both patient morbidity and
mortality, however, this open-heart surgical intervention is highly invasive, traumatic, expensive and has a limited
lifetime. Because most CABG grafts utilize re-purposed veins, 50% become occluded within ten years after
bypass surgery. PCI procedures are provided over a 24-hour hospital stay, have one-two days of recovery time
and cost approximately one-fourth of CABG yet are currently administered to only 10% of CTO patients. In the
most common PCI procedure, subintimal crossing, a mechanical wire is advanced past the CTO inside the vessel
wall. Few interventionalists practice subintimal crossing because the procedure is difficult, risky and associated
with higher MACE, restenosis, acute MI and death. Although many intravascular devices have been introduced
to perform PCI true-lumen CTO crossing, all have failed in the coronary arteries. Failure of these previous
devices is due to at least one of three causes: 1) large-diameter catheters that are too rigid with poor steerability;
2) non-specific injury to the vessel wall resulting from CTO cutting; and 3) absence of a navigational guidance
system based on real-time imaging of the catheter tip relative to the arterial wall. An optoacoustic (OA) and
ultrasound (US) image-guided cold laser wire (CLW) is proposed that provides controlled cutting that will allow
any interventional cardiologist to provide patients safe and efficacious PCI true-lumen CTO crossing.
Development of the transvenous OA/US image-guided CLW will be accomplished by completing three specific
aims: Aim 1: Develop an Optoacoustic (OA)/Ultrasound (US) Transvenous Image-Guided Cold Laser
Wire; Aim 2: Test CLW True-Lumen PCI CTO Crossing in ex vivo Human CABG Hearts; Aim 3: Test CLW
True-Lumen PCI Crossing of Calcified CTOs in in vivo Animal Models. Successful completion of the
proposed research and development program will introduce a true-lumen PCI CTO crossing procedure that
when followed by stenting can establish a superior and new treatment paradigm for interventional cardiology
and can impact other surgical disciplines.
抽象的
冠状动脉慢性完全闭塞 (CTO) 是由硬纤维钙化物质组成的动脉粥样硬化斑块
100% 限制管腔横截面,导致受影响动脉中的血流完全停止
至少三个月。 CTO 症状包括呼吸短促、慢性疲劳和胸痛。这
三种主要的 CTO 治疗方案是药物治疗 (MT)、冠状动脉旁路移植术 (CABG) 和
经皮冠状动脉介入治疗(PCI)。 MT 可以减轻胸痛等症状,但无法解决
潜在的疾病机制。 CABG 确实显着改善了患者的发病率和
然而,这种直视手术干预具有高度侵入性、创伤性、昂贵且有限的死亡率。
寿命。由于大多数 CABG 移植物使用重新用途的静脉,因此 50% 在移植后十年内发生闭塞
心脏搭桥手术。 PCI 手术在 24 小时住院期间提供,有 1 至 2 天的恢复时间
其费用约为 CABG 的四分之一,但目前只有 10% 的 CTO 患者接受这种治疗。在
最常见的 PCI 手术,内膜下穿越,机械线穿过血管内的 CTO
墙。很少有介入医生进行内膜下穿越,因为该手术困难、风险大且相关性强。
具有较高的 MACE、再狭窄、急性心肌梗死和死亡。尽管已经引入了许多血管内装置
进行PCI真腔CTO穿越,冠状动脉均失败。之前的这些失败
装置的损坏至少是由以下三个原因之一造成的:1)大直径导管过于刚性,可操纵性差;
2)CTO切割造成的血管壁非特异性损伤; 3)缺乏导航指导
基于导管尖端相对于动脉壁的实时成像的系统。光声 (OA) 和
提出了超声(美国)图像引导冷激光线(CLW),可提供受控切割,从而允许
任何介入心脏病专家为患者提供安全有效的 PCI 真腔 CTO 穿越。
经静脉 OA/US 图像引导 CLW 的开发将通过完成三个具体任务来完成
目标: 目标 1:开发光声 (OA)/超声 (美国) 经静脉图像引导冷激光
金属丝;目标 2:在离体人 CABG 心脏中测试 CLW True-Lumen PCI CTO Crossing;目标 3:测试 CLW
体内动物模型中钙化 CTO 的真腔 PCI 穿越。圆满完成了
拟议的研发计划将引入真腔 PCI CTO 交叉程序
随后进行支架置入术可以为介入心脏病学建立一种优越的、新的治疗范例
并可能影响其他外科学科。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARC David FELDMAN其他文献
MARC David FELDMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARC David FELDMAN', 18)}}的其他基金
Transvenous Optoacoustic-Ultrasound Guided Cold Laser Wire for Crossing Coronary Chronic Total Occlusion
经静脉光声超声引导冷激光线穿越冠状动脉慢性完全闭塞
- 批准号:
10612422 - 财政年份:2022
- 资助金额:
$ 63.44万 - 项目类别:
LV SV using Admittance for Hemodynamically Unstable Arrhythmia Detection
使用导纳进行 LV SV 检测血流动力学不稳定心律失常
- 批准号:
8887475 - 财政年份:2015
- 资助金额:
$ 63.44万 - 项目类别:
LV SV using Admittance for Hemodynamically Unstable Arrhythmia Detection
使用导纳进行 LV SV 检测血流动力学不稳定心律失常
- 批准号:
9250203 - 财政年份:2015
- 资助金额:
$ 63.44万 - 项目类别:
Detection of plaque based macrophages with light
用光检测基于斑块的巨噬细胞
- 批准号:
8394614 - 财政年份:2010
- 资助金额:
$ 63.44万 - 项目类别:
Detection of plaque based macrophages with light
用光检测基于斑块的巨噬细胞
- 批准号:
8259055 - 财政年份:2010
- 资助金额:
$ 63.44万 - 项目类别:
Detection of plaque based macrophages with light
用光检测基于斑块的巨噬细胞
- 批准号:
7930086 - 财政年份:2010
- 资助金额:
$ 63.44万 - 项目类别:
Detection of plaque based macrophages with light
用光检测基于斑块的巨噬细胞
- 批准号:
8195920 - 财政年份:2010
- 资助金额:
$ 63.44万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 63.44万 - 项目类别:
Research Grant